Submission of proceedings of the 37th Annual General Meeting held on 4th August 2026

Date: 04th August 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street, Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001 Scrip Symbol- SUDEEPPHRM Scrip Code: 544619 Sub: Proceedings of the 37th Annual General Meeting Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am, With reference to the above-mentioned subject, we hereby enclose the proceedings of the 37th Annual General Meeting (“AGM”) held on Tuesday, 04th August, 2026 at 11:00 am (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). In this regard, kindly find enclosed herewith proceedings as required under Regulation 30, Part A of Schedule III of the Listing Regulations. Kindly take the same on record. Thanking you, For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 ENCL: A/a CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Proceedings of the 37th Annual General Meeting of Sudeep Pharma Limited The 37th Annual General Meeting (“AGM”) of the Members of Sudeep Pharma Limited (“the Company”) was held on Tuesday, 4th August 2026 at 11:00 a.m., IST through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). Directors Present & In Attendance Mr. Bhayani Sujit Jaysukh Chairman & Managing Director Mr. Shanil Sujit Bhayani Whole Time Director Mr. Ajay Shrirang Kandelkar Mr. Samaresh Parida Independent Director & Chairman of Audit Committee Mr. Raghunandan Sathyanarayan Rao Independent Director & Chairman of Risk Management Committee Ms. Reshma Patel Independent Director & Chairperson of Nomination and Remuneration Committee Mr. Sujit Gulati Independent Director & Chairman of Stakeholder Relationship Committee Mr. Ketan Vyas Chief Financial Officer Ms. Dimple Mehta Company Secretary & Compliance Officer Auditors & Scrutinizer Present: Representatives of Statutory Auditors – Mr. Jeyur Shah M/s B S R and Co., Chartered Accountants Representatives Secretarial Auditors & Scrutinizer– Mr. Parth Nashikar M/s H M Mehta & Associates, Company Secretaries Speaker Shareholders: Mr. Dnyaneshwar K Bhagwat – Mumbai, Maharashtra Mr. Sathish Shah - Mumbai, Maharashtra Mr. Himanshu Anilbhai Trivedi – Vadodara, Gujarat Mr. Lokesh Gupta – New Delhi Mr. Samrat Sarkar - Kolkata CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Ms. Dimple Mehta, Company Secretary, welcomed all the Members, Directors, Auditors and other invitees to the 37th Annual General Meeting of Sudeep Pharma Limited. The Company Secretary confirmed that the requisite quorum was present and requested the Chairman to commence the proceedings of the meeting. Mr. Sujit Bhayani chaired the meeting. As the requisite quorum was present, the Chairman called the meeting to order. The Company Secretary introduced all the directors present at the meeting to all the members. The Company Secretary, on behalf of the Chairman, informed the members as below: 1. Attendance: That the meeting was held through Video Conference without the physical presence of the members at a common venue in accordance with the Circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Facility for joining the meeting through Video Conference was made available for the members on a first come first served basis. As the AGM was held through Video Conference, the facility for appointment of proxies by the members was not applicable. 2. E-voting: The Company had provided its members the facility to cast their vote electronically, on all resolutions set forth in the Notice of AGM. Members who had participated in the AGM and not casted their votes electronically was provided an opportunity to cast their votes on the NSDL platform during the meeting and for 15 minutes from the closure of the meeting. It was further informed that since the AGM was held through VC facility and resolutions were put to vote only through e-voting, the practice of proposing and seconding of resolutions was not followed. The Board had appointed Mr. Hemang Mehta, from M/s. H M Mehta & Associates, Practicing Company Secretaries as Scrutinizer to scrutinize the votes casted through remote e- voting and during the meeting and submit the report within two working days from the conclusion of the AGM. The results would be announced by posting it on the Company’s website, website of stock exchanges i.e. BSE Ltd and National Stock Exchange of India Ltd. (NSE) and on the NSDL website. 3. Statutory Registers: The Statutory Registers and documents required to be kept open for inspection were available to Members electronically. 4. Statutory Auditors Report and Secretarial Auditors Report: There were no qualifications, observations, adverse remarks or comments in the Statutory Auditor’s Report and the Secretarial Audit Report which would have an adverse effect on the functioning of the Company. 5. Notice of 37th Annual General Meeting: As Notice of the 37th AGM was already circulated to the members, with the consent of the Members, the Notice convening the meeting was taken as read. CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Following items of business, as per the Notice of AGM dated 10th July 2026, were transacted at the meeting: Ordinary Businesses: 1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereon. 2. Re-appointment of Mr. Ajay Shrirang Kandelkar (DIN: 10773491) as a director, who retires by rotation and being eligible, offers himself for re-appointment. 3. To declare dividend on equity shares for the FY 2025-26. Special businesses: 4. Ratification of remuneration to be paid to Cost Auditors for FY 2026-27. 5. To Appoint Mr. Hemang Mehta, a proprietor of H. M. Mehta & Associates, Peer reviewed Practicing Company Secretary, as Secretarial Auditor of the Company for a term of 5 (Five) consecutive years and fix their remuneration. 6. Appointment of Mr. Milin Mehta as a Director (Non- Executive & Non-Independent). 7. To ratify ‘Sudeep Pharma Employee Stock Option Scheme 2025’. 8. To approve the grant of employee stock options to the eligible employees of the subsidiary company(ies) of the Company under “Sudeep Pharma Employee Stock Option Scheme 2025. 9. To approve the grant of employee stock options to the eligible employees of the group company including associate company(ies) of the Company under “Sudeep Pharma Employee Stock Option Scheme 2025”. 10. To Change the Remuneration of Mr Ajay Shrirang Kandelkar (DIN: 10773491) as Whole Time Director w.e.f. 1st April, 2026. 11. To adopt new set of Articles of Association (AOA). CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com After that, the Chair [Showing first 8,000 characters — download PDF for full document]